405 related articles for article (PubMed ID: 16778164)
1. Fatty acid synthase and cancer: new application of an old pathway.
Kuhajda FP
Cancer Res; 2006 Jun; 66(12):5977-80. PubMed ID: 16778164
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid synthase: a metabolic oncogene in prostate cancer?
Baron A; Migita T; Tang D; Loda M
J Cell Biochem; 2004 Jan; 91(1):47-53. PubMed ID: 14689581
[TBL] [Abstract][Full Text] [Related]
3. [Fatty acid synthase and prostate cancer].
Wang KF; Wu B
Zhonghua Nan Ke Xue; 2008 Aug; 14(8):740-2. PubMed ID: 18817351
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.
Menendez JA; Lupu R
Arch Immunol Ther Exp (Warsz); 2004; 52(6):414-26. PubMed ID: 15577743
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
[TBL] [Abstract][Full Text] [Related]
6. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma.
Milgraum LZ; Witters LA; Pasternack GR; Kuhajda FP
Clin Cancer Res; 1997 Nov; 3(11):2115-20. PubMed ID: 9815604
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.
Zeng L; Biernacka KM; Holly JM; Jarrett C; Morrison AA; Morgan A; Winters ZE; Foulstone EJ; Shield JP; Perks CM
Endocr Relat Cancer; 2010 Jun; 17(2):539-51. PubMed ID: 20356977
[TBL] [Abstract][Full Text] [Related]
8. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of triclosan to fatty acid synthase from goose uropygial glands and human breast cancer cells in vitro].
Wang YQ; Lai BS; Anderson VE
Ai Zheng; 2003 Mar; 22(3):270-3. PubMed ID: 12654184
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride.
Schmidt LJ; Ballman KV; Tindall DJ
Prostate; 2007 Jul; 67(10):1111-20. PubMed ID: 17477363
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
[TBL] [Abstract][Full Text] [Related]
12. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
Zhou W; Tu Y; Simpson PJ; Kuhajda FP
Oncogene; 2009 Aug; 28(33):2979-87. PubMed ID: 19543323
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of fatty acid synthase for lung cancer treatment.
Orita H; Coulter J; Lemmon C; Tully E; Vadlamudi A; Medghalchi SM; Kuhajda FP; Gabrielson E
Clin Cancer Res; 2007 Dec; 13(23):7139-45. PubMed ID: 18056164
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
Puig T; Vázquez-Martín A; Relat J; Pétriz J; Menéndez JA; Porta R; Casals G; Marrero PF; Haro D; Brunet J; Colomer R
Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
[TBL] [Abstract][Full Text] [Related]
15. MRNA stability and overexpression of fatty acid synthase in human breast cancer cell lines.
Hunt DA; Lane HM; Zygmont ME; Dervan PA; Hennigar RA
Anticancer Res; 2007; 27(1A):27-34. PubMed ID: 17352212
[TBL] [Abstract][Full Text] [Related]
16. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
17. Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays.
Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
Int J Mol Med; 2008 Oct; 22(4):433-9. PubMed ID: 18813848
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.
Menendez JA; Lupu R
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):346-57. PubMed ID: 16778562
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer.
Wang YY; Kuhajda FP; Li J; Finch TT; Cheng P; Koh C; Li T; Sokoll LJ; Chan DW
J Exp Ther Oncol; 2004 Jul; 4(2):101-10. PubMed ID: 15500005
[TBL] [Abstract][Full Text] [Related]
20. Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals.
Puig T; Relat J; Marrero PF; Haro D; Brunet J; Colomer R
Anticancer Res; 2008; 28(6A):3671-6. PubMed ID: 19189648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
